Anti-cancer Drugs Market

Anti-cancer Drugs Market Analysis by Cytotoxics, Hormonal Therapy, and Targeted Therapy for Prostate Cancer, Lung Cancer, Breast Cancer, Melanoma, and Colon & Rectum Cancer from 2024 to 2034

Analysis of Anti-cancer Drugs Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

author

Author:

Md Sanaullah

author

Editor:

Anushree Karale

Anti-cancer Drugs Market
  • FACT4350MR
  • 24 Nov 2023
  • Healthcare
  • 170 Pages
  • 32 Tables
  • 160 Figures
  • Base Value(2024): 198957.9 Mn
  • Forecast Value (2034): 411789.3 Mn
  • CAGR (2034): 7.5%

Table of Content

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Market Background
  • 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
  • 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Drug Class
    • 5.1. Cytotoxic
    • 5.2. Hormonal Therapy
    • 5.3. Targeted Therapy
      • 5.3.1. Monoclonal antibodies
      • 5.3.2. Small molecule inhibitors
  • 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Cancer Type
    • 6.1. Prostate Cancer
    • 6.2. Lung Cancer
    • 6.3. Breast Cancer
    • 6.4. Melanoma
    • 6.5. Colon and Rectum Cancer
    • 6.6. Others
  • 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
    • 7.1. Hospital Pharmacies
    • 7.2. Retail Pharmacies
  • 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    • 8.1. North America
    • 8.2. Latin America
    • 8.3. Western Europe
    • 8.4. Eastern Europe
    • 8.5. South Asia and Pacific
    • 8.6. East Asia
    • 8.7. Middle East and Africa
  • 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 16. Key Countries Market Analysis
  • 17. Market Structure Analysis
  • 18. Competition Analysis
    • 18.1. F. Hoffmann-La Roche Ltd
    • 18.2. AbbVie
    • 18.3. Eli Lilly and Company
    • 18.4. Novartis AG
    • 18.5. Pfizer Inc
    • 18.6. Bayer AG
    • 18.7. AstraZeneca
    • 18.8. Takeda Pharmaceutical Company Limited
    • 18.9. Merck & Co., Inc.
    • 18.10. CELGENE CORPORATION
  • 19. Assumptions & Acronyms Used
  • 20. Research Methodology

List Of Table

Table 01: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 02: Global Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 03: Global Market Value (US$ Million) Forecast by Cancer Type, 2019 to 2034

Table 04: Global Market Value (US$ Million) Forecast by Distribution Channel , 2019 to 2034

Table 05: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 06: North America Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 07: North America Market Value (US$ Million) Forecast by Cancer Type, 2019 to 2034

Table 08: North America Market Value (US$ Million) Forecast by Distribution Channel , 2019 to 2034

Table 09: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 10: Latin America Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 11: Latin America Market Value (US$ Million) Forecast by Cancer Type, 2019 to 2034

Table 12: Latin America Market Value (US$ Million) Forecast by Distribution Channel , 2019 to 2034

Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 14: Western Europe Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 15: Western Europe Market Value (US$ Million) Forecast by Cancer Type, 2019 to 2034

Table 16: Western Europe Market Value (US$ Million) Forecast by Distribution Channel , 2019 to 2034

Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 18: Eastern Europe Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 19: Eastern Europe Market Value (US$ Million) Forecast by Cancer Type, 2019 to 2034

Table 20: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel , 2019 to 2034

Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Cancer Type, 2019 to 2034

Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel , 2019 to 2034

Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 26: East Asia Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 27: East Asia Market Value (US$ Million) Forecast by Cancer Type, 2019 to 2034

Table 28: East Asia Market Value (US$ Million) Forecast by Distribution Channel , 2019 to 2034

Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Drug Class, 2019 to 2034

Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Cancer Type, 2019 to 2034

Table 32: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel , 2019 to 2034

List Of Figures

Figure 01: Global Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 02: Global Market Value (US$ Million) by Cancer Type, 2024 to 2034

Figure 03: Global Market Value (US$ Million) by Distribution Channel , 2024 to 2034

Figure 04: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 05: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 06: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 07: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 08: Global Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 09: Global Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 10: Global Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 11: Global Market Value (US$ Million) Analysis by Cancer Type, 2019 to 2034

Figure 12: Global Market Value Share (%) and BPS Analysis by Cancer Type, 2024 to 2034

Figure 13: Global Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034

Figure 14: Global Market Value (US$ Million) Analysis by Distribution Channel , 2019 to 2034

Figure 15: Global Market Value Share (%) and BPS Analysis by Distribution Channel , 2024 to 2034

Figure 16: Global Market Y-o-Y Growth (%) Projections by Distribution Channel , 2024 to 2034

Figure 17: Global Market Attractiveness by Drug Class, 2024 to 2034

Figure 18: Global Market Attractiveness by Cancer Type, 2024 to 2034

Figure 19: Global Market Attractiveness by Distribution Channel , 2024 to 2034

Figure 20: Global Market Attractiveness by Region, 2024 to 2034

Figure 21: North America Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 22: North America Market Value (US$ Million) by Cancer Type, 2024 to 2034

Figure 23: North America Market Value (US$ Million) by Distribution Channel , 2024 to 2034

Figure 24: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 28: North America Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 29: North America Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 30: North America Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 31: North America Market Value (US$ Million) Analysis by Cancer Type, 2019 to 2034

Figure 32: North America Market Value Share (%) and BPS Analysis by Cancer Type, 2024 to 2034

Figure 33: North America Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034

Figure 34: North America Market Value (US$ Million) Analysis by Distribution Channel , 2019 to 2034

Figure 35: North America Market Value Share (%) and BPS Analysis by Distribution Channel , 2024 to 2034

Figure 36: North America Market Y-o-Y Growth (%) Projections by Distribution Channel , 2024 to 2034

Figure 37: North America Market Attractiveness by Drug Class, 2024 to 2034

Figure 38: North America Market Attractiveness by Cancer Type, 2024 to 2034

Figure 39: North America Market Attractiveness by Distribution Channel , 2024 to 2034

Figure 40: North America Market Attractiveness by Country, 2024 to 2034

Figure 41: Latin America Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 42: Latin America Market Value (US$ Million) by Cancer Type, 2024 to 2034

Figure 43: Latin America Market Value (US$ Million) by Distribution Channel , 2024 to 2034

Figure 44: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 48: Latin America Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 51: Latin America Market Value (US$ Million) Analysis by Cancer Type, 2019 to 2034

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Cancer Type, 2024 to 2034

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034

Figure 54: Latin America Market Value (US$ Million) Analysis by Distribution Channel , 2019 to 2034

Figure 55: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel , 2024 to 2034

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel , 2024 to 2034

Figure 57: Latin America Market Attractiveness by Drug Class, 2024 to 2034

Figure 58: Latin America Market Attractiveness by Cancer Type, 2024 to 2034

Figure 59: Latin America Market Attractiveness by Distribution Channel , 2024 to 2034

Figure 60: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 61: Western Europe Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 62: Western Europe Market Value (US$ Million) by Cancer Type, 2024 to 2034

Figure 63: Western Europe Market Value (US$ Million) by Distribution Channel , 2024 to 2034

Figure 64: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 68: Western Europe Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 71: Western Europe Market Value (US$ Million) Analysis by Cancer Type, 2019 to 2034

Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Cancer Type, 2024 to 2034

Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034

Figure 74: Western Europe Market Value (US$ Million) Analysis by Distribution Channel , 2019 to 2034

Figure 75: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel , 2024 to 2034

Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel , 2024 to 2034

Figure 77: Western Europe Market Attractiveness by Drug Class, 2024 to 2034

Figure 78: Western Europe Market Attractiveness by Cancer Type, 2024 to 2034

Figure 79: Western Europe Market Attractiveness by Distribution Channel , 2024 to 2034

Figure 80: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 81: Eastern Europe Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 82: Eastern Europe Market Value (US$ Million) by Cancer Type, 2024 to 2034

Figure 83: Eastern Europe Market Value (US$ Million) by Distribution Channel , 2024 to 2034

Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Cancer Type, 2019 to 2034

Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Cancer Type, 2024 to 2034

Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034

Figure 94: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel , 2019 to 2034

Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel , 2024 to 2034

Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel , 2024 to 2034

Figure 97: Eastern Europe Market Attractiveness by Drug Class, 2024 to 2034

Figure 98: Eastern Europe Market Attractiveness by Cancer Type, 2024 to 2034

Figure 99: Eastern Europe Market Attractiveness by Distribution Channel , 2024 to 2034

Figure 100: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 101: South Asia and Pacific Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 102: South Asia and Pacific Market Value (US$ Million) by Cancer Type, 2024 to 2034

Figure 103: South Asia and Pacific Market Value (US$ Million) by Distribution Channel , 2024 to 2034

Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Cancer Type, 2019 to 2034

Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Cancer Type, 2024 to 2034

Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034

Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel , 2019 to 2034

Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel , 2024 to 2034

Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel , 2024 to 2034

Figure 117: South Asia and Pacific Market Attractiveness by Drug Class, 2024 to 2034

Figure 118: South Asia and Pacific Market Attractiveness by Cancer Type, 2024 to 2034

Figure 119: South Asia and Pacific Market Attractiveness by Distribution Channel , 2024 to 2034

Figure 120: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 121: East Asia Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 122: East Asia Market Value (US$ Million) by Cancer Type, 2024 to 2034

Figure 123: East Asia Market Value (US$ Million) by Distribution Channel , 2024 to 2034

Figure 124: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 128: East Asia Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 129: East Asia Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 131: East Asia Market Value (US$ Million) Analysis by Cancer Type, 2019 to 2034

Figure 132: East Asia Market Value Share (%) and BPS Analysis by Cancer Type, 2024 to 2034

Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034

Figure 134: East Asia Market Value (US$ Million) Analysis by Distribution Channel , 2019 to 2034

Figure 135: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel , 2024 to 2034

Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel , 2024 to 2034

Figure 137: East Asia Market Attractiveness by Drug Class, 2024 to 2034

Figure 138: East Asia Market Attractiveness by Cancer Type, 2024 to 2034

Figure 139: East Asia Market Attractiveness by Distribution Channel , 2024 to 2034

Figure 140: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 141: Middle East and Africa Market Value (US$ Million) by Drug Class, 2024 to 2034

Figure 142: Middle East and Africa Market Value (US$ Million) by Cancer Type, 2024 to 2034

Figure 143: Middle East and Africa Market Value (US$ Million) by Distribution Channel , 2024 to 2034

Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Drug Class, 2019 to 2034

Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034

Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034

Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Cancer Type, 2019 to 2034

Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Cancer Type, 2024 to 2034

Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034

Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel , 2019 to 2034

Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel , 2024 to 2034

Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel , 2024 to 2034

Figure 157: Middle East and Africa Market Attractiveness by Drug Class, 2024 to 2034

Figure 158: Middle East and Africa Market Attractiveness by Cancer Type, 2024 to 2034

Figure 159: Middle East and Africa Market Attractiveness by Distribution Channel , 2024 to 2034

Figure 160: Middle East and Africa Market Attractiveness by Country, 2024 to 2034

Anti-cancer Drugs Market

Free Sample Buy Report Now

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services